£100.99

CRC Press Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 76 days • 65 data points (No recent data available)

Historical
Generating forecast...
£123.54 £98.74 £104.15 £109.56 £114.97 £120.38 £125.80 25 January 2026 12 February 2026 03 March 2026 22 March 2026 10 April 2026

Price Distribution

Price distribution over 76 days • 5 price levels

Days at Price
Current Price
17 days · current 2 days 14 days 15 days 17 days 0 4 9 13 17 £101 £106 £106 £120 £124 Days at Price

Price Analysis

Most common price: £101 (17 days, 26.2%)

Price range: £101 - £124

Price levels: 5 different prices over 65 days

Description

A disease is defined as rare if the prevalence is fewer than 200,000 in the United States. It is estimated that there are more than 7,000 rare diseases, which collectively affect 30 million Americans or 10% of the US population. This diverse and complex disease area poses challenges for patients, caregivers, regulators, drug developers, and other stakeholders. This book is proposed to give an overview of the common issues facing rare disease drug developers, summarize challenges specific to clinical development in small populations, discuss drug development strategies in the evolving regulatory environment, explain generation and utilization of different data and evidence inside and beyond clinical trials, and use recent examples to demonstrate these challenges and the development strategies that respond to the challenges. Key Features: • Rare disease. • Drug development. • Innovative clinical trial design. • Regulatory approval. • Real-world evidence.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
13 February 2023
Listed Since
12 July 2022

Barcode

No barcode data available

Similar Products You Might Like

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)
95% match

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£115.22 24 Feb 2026
Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
92% match

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

£128.80 11 Jan 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
92% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£60.89 06 Mar 2026
Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)
92% match

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£115.00 27 Feb 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
92% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£44.44 21 Feb 2026
Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/CRC Biostatistics)
92% match

Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/CRC Biostatistics)

CRC Press

£85.00 08 Mar 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
92% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 27 Feb 2026
Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)
92% match

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£97.00 09 Mar 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)
92% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.33 20 Feb 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
92% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£119.60 23 Feb 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
92% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£45.07 07 Mar 2026
Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (Chapman & Hall/CRC Biostatistics Series)
92% match

Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£96.00 19 Apr 2026
Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)
91% match

Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.27 15 Feb 2026
Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)
91% match

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£92.00 25 Jan 2026
Statistics in Drug Research: Methodologies and Recent Developments: 10 (Chapman & Hall/CRC Biostatistics)
91% match

Statistics in Drug Research: Methodologies and Recent Developments: 10 (Chapman & Hall/CRC Biostatistics)

CRC Press

£239.20 10 Jan 2026
Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)
91% match

Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£142.60 08 Mar 2026
Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
91% match

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£100.00 09 Mar 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
91% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 08 Mar 2026
Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/Crc Biostatistics)
91% match

Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/Crc Biostatistics)

CRC Press

£59.47 31 Mar 2026
Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (Chapman & Hall/CRC Biostatistics Series)
91% match

Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.49 27 Feb 2026
Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)
91% match

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£49.34 07 Mar 2026
CRC Press Bayesian Methods in Pharmaceutical Research Book
91% match

CRC Press Bayesian Methods in Pharmaceutical Research Book

CRC Press

£102.77 20 Apr 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
91% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£97.00 09 Mar 2026
Innovative Designs and Analyses for Small Population Clinical Trials: Development Strategies and Operational Engagement for Pediatric and Rare Diseases (ICSA Book Series in Statistics)
91% match

Innovative Designs and Analyses for Small Population Clinical Trials: Development Strategies and Operational Engagement for Pediatric and Rare Diseases (ICSA Book Series in Statistics)

Springer

£107.29 13 Apr 2026